Explore
Validate
Learn17400-1-AP
antibody from Proteintech Group
Targeting: FGF1
AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17400-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#17400-1-AP, RRID:AB_2103758
- Product name
- FGF1 antibody
- Antibody type
- Polyclonal
- Description
- FGF1 antibody (Cat. #17400-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Lipid-Driven OLR1/FOXM1/FGF19 Axis Orchestrates Crosstalk in an Epithelial-Fibroblast Positive Feedback Promoting Progesterone Resistance in Endometrial Cancer.
CircZBTB46 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miRNA-326/FGF1 axis.
Madecassoside mitigates acute myocardial infarction injury by activating the PKCB/SPARC signaling pathway.
Hepatocyte-Derived FGF1 Alleviates Isoniazid and Rifampicin-Induced Liver Injury by Regulating HNF4α-Mediated Bile Acids Synthesis.
Colonic epithelial-derived FGF1 drives intestinal stem cell commitment toward goblet cells to suppress inflammatory bowel disease.
Saturated fatty acids stimulate cytokine production in tanycytes via the PP2Ac-dependent signaling pathway.
Sitagliptin therapy improves myocardial perfusion and arteriolar collateralization in chronically ischemic myocardium: A pilot study.
A derivant of ginsenoside CK and its inhibitory effect on hepatocellular carcinoma.
Ectoderm-derived frontal bone mesenchymal stem cells promote traumatic brain injury recovery by alleviating neuroinflammation and glutamate excitotoxicity partially via FGF1.
Non-mitogenic fibroblast growth factor 1 protects against ischemic stroke by regulating microglia/macrophage polarization through Nrf2 and NF-κB pathways.
Li X, Qi Y, Wu Y, Bi X, Wang Y, Wang J, Wang J, Zhang L, Xiao H, Wang J
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Jan;13(6):e11943
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Jan;13(6):e11943
CircZBTB46 alleviates metabolic dysfunction-associated steatotic liver disease by targeting miRNA-326/FGF1 axis.
Zeng QM, Hu T, Jiang W, Teng X, Wu D, Tang H, Liu CH
Cell death discovery 2026 Jan 9;12(1):17
Cell death discovery 2026 Jan 9;12(1):17
Madecassoside mitigates acute myocardial infarction injury by activating the PKCB/SPARC signaling pathway.
Wang P, Yang JQ, Xu DD, Zhang SJ, Lu S, Ji Y
Acta pharmacologica Sinica 2025 Jun;46(6):1624-1638
Acta pharmacologica Sinica 2025 Jun;46(6):1624-1638
Hepatocyte-Derived FGF1 Alleviates Isoniazid and Rifampicin-Induced Liver Injury by Regulating HNF4α-Mediated Bile Acids Synthesis.
Lin Q, Zhang J, Qi J, Tong J, Chen S, Zhang S, Liu X, Lou H, Lv J, Lin R, Xie J, Jin Y, Wang Y, Ying L, Wu J, Niu J
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Feb;12(7):e2408688
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Feb;12(7):e2408688
Colonic epithelial-derived FGF1 drives intestinal stem cell commitment toward goblet cells to suppress inflammatory bowel disease.
Lin Q, Zhang S, Zhang J, Jin Y, Chen T, Lin R, Lv J, Xu W, Wu T, Tian S, Ying L, Li X, Huang Z, Niu J
Nature communications 2025 Apr 5;16(1):3264
Nature communications 2025 Apr 5;16(1):3264
Saturated fatty acids stimulate cytokine production in tanycytes via the PP2Ac-dependent signaling pathway.
Liu D, Wang T, Zhao X, Chen J, Yang T, Shen Y, Zhou YD
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2024 Jun;44(6):985-999
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2024 Jun;44(6):985-999
Sitagliptin therapy improves myocardial perfusion and arteriolar collateralization in chronically ischemic myocardium: A pilot study.
Sabe SA, Harris DD, Broadwin M, Sabra M, Xu CM, Banerjee D, Abid MR, Sellke FW
Physiological reports 2023 Jun;11(11):e15744
Physiological reports 2023 Jun;11(11):e15744
A derivant of ginsenoside CK and its inhibitory effect on hepatocellular carcinoma.
Zhang J, Tong Y, Lu X, Dong F, Ma X, Yin S, He Y, Liu Y, Liu Q, Fan D
Life sciences 2022 Sep 1;304:120698
Life sciences 2022 Sep 1;304:120698
Ectoderm-derived frontal bone mesenchymal stem cells promote traumatic brain injury recovery by alleviating neuroinflammation and glutamate excitotoxicity partially via FGF1.
Qin Q, Wang T, Xu Z, Liu S, Zhang H, Du Z, Wang J, Wang Y, Wang Z, Yuan S, Wu J, He W, Wang C, Yan X, Wang Y, Jiang X
Stem cell research & therapy 2022 Jul 26;13(1):341
Stem cell research & therapy 2022 Jul 26;13(1):341
Non-mitogenic fibroblast growth factor 1 protects against ischemic stroke by regulating microglia/macrophage polarization through Nrf2 and NF-κB pathways.
Dordoe C, Wang X, Lin P, Wang Z, Hu J, Wang D, Fang Y, Liang F, Ye S, Chen J, Zhao Y, Xiong Y, Yang Y, Lin L, Li X
Neuropharmacology 2022 Jul 1;212:109064
Neuropharmacology 2022 Jul 1;212:109064
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human brain using 17400-1-AP(FGF1 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The FGF1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human FGF1. This antibody recognizes human, mouse, rat antigen. The FGF1 antibody has been validated for the following applications: ELISA, IHC analysis.
